Sarampo

McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo  Resumo

UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].Texto completo

Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2023. Feb 2023 [internet publication].Texto completo

Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2023. Feb 2023 ​[internet publication].Texto completo

American Academy of Pediatrics Committee on Infectious Diseases. Measles. In Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.Texto completo

1. Cherry JD, Lugo D. Measles virus. In: Feigin and Cherry JD, Demmler-Harrison GJ, Kaplan SL, et al, eds. Feigin and Cherry's textbook of pediatric infectious diseases. 8th ed. Philadelphia, PA: Elsevier; 2018:1754-70

2. Measles vaccines: WHO position paper – April 2017. Wkly Epidemiol Rec. 2017 Apr 28;92(17):205-27.Texto completo  Resumo

3. Gastanaduy P, Haber P, Rota PA, et al. Measles. In: Hall E, Wodi AP, Hamborsky J, et al, eds. CDC Pink Book 2021: Epidemiology and vaccine-preventable diseases. 14th ed. Washington, D.C. Public Health Foundation, 2021Texto completo

4. Patel MK, Goodson JL, Alexander JP Jr, et al. Progress Toward Regional Measles Elimination - Worldwide, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020 Nov 13;69(45):1700-1705.Texto completo  Resumo

5. Centers for Disease Control and Prevention. Measles cases and outbreaks. Sep 2023 [internet publication].Texto completo

6. World Health Organization. Europe observes a 4-fold increase in measles cases in 2017 compared to previous year. February 2018 [internet publication].Texto completo

7. World Health Organization. Measles in Europe: record number of both sick and immunized. February 2019 [internet publication].Texto completo

8. World Health Organization. European Region loses ground in effort to eliminate measles. Aug 2019 [internet publication].Texto completo

9. Masresha BG, Hatcher C, Lebo E, et al. Progress toward measles elimination - African region, 2017-2021. MMWR Morb Mortal Wkly Rep. 2023 Sep 8;72(36):985-91.Texto completo  Resumo

10. Minta AA, Ferrari M, Antoni S, et al. Progress toward regional measles elimination - Worldwide, 2000-2021. MMWR Morb Mortal Wkly Rep. 2022 Nov 25;71(47):1489-95.Texto completo  Resumo

11. Hübschen JM, Gouandjika-Vasilache I, Dina J. Measles. Lancet. 2022 Feb 12;399(10325):678-90.Texto completo  Resumo

12. McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo  Resumo

13. Di Pietrantonj C, Rivetti A, Marchione P, et al. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407.Texto completo  Resumo

14. UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].Texto completo

15. Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2023. Feb 2023 [internet publication].Texto completo

16. Krow-Lucal E, Marin M, Shepersky L, et al. Measles, mumps, rubella vaccine (PRIORIX): recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 18;71(46):1465-70.Texto completo  Resumo

17. Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older, United States, 2023. Feb 2023 ​[internet publication].Texto completo

18. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections and diseases​ - Rubeola / Measles. May 2023 [internet publication].Texto completo

19. Hyle EP, Rao SR, Jentes ES, et al. Missed opportunities for measles, mumps, rubella vaccination among departing U.S. adult travelers receiving pretravel health consultations. Ann Intern Med. 2017 Jul 18;167(2):77-84. Resumo

20. American Academy of Pediatrics Committee on Infectious Diseases. Measles. In Kimberlin DW, Brady MT, Jackson MA, et al, eds. Red Book: 2021 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.Texto completo

21. Hambidge SJ, Newcomer SR, Narwaney KJ, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun;133(6):e1492-9.Texto completo  Resumo

22. Klein NP, Lewis E, Fireman B, et al. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb;135(2):e321-9.Texto completo  Resumo

23. Scott P, Moss WJ, Gilani Z, et al. Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis. 2011 Jul;204 Suppl 1:S164-78.Texto completo  Resumo

24. US Department of Health and Human Services. Panel on opportunistic infections in children with and exposed to HIV. Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV. ​Oct 2019 [internet publication].Texto completo

25. Guerra FM, Crowcroft NS, Friedman L, et al. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review. Vaccine. 2018 Feb 28;36(10):1248-1255. Resumo

26. Nic Lochlainn LM, de Gier B, van der Maas N, et al. Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1235-1245.Texto completo  Resumo

27. Nic Lochlainn LM, de Gier B, van der Maas N, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Nov;19(11):1246-1254.Texto completo  Resumo

28. Centers for Disease Control and Prevention. General best practice guidelines for immunization. Aug 2023 [internet publication].Texto completo

29. Hviid A, Hansen JV, Frisch M, et al. Measles, mumps, rubella vaccination and autism: A nationwide cohort study. 2019 Apr 16;170(8):513-20.Texto completo  Resumo

30. Maglione MA, Das L, Raaen L, et al. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics. 2014 Aug;134(2):325-37.Texto completo  Resumo

31. Centers for Disease Control and Prevention.​ Measles / Rubeola: 2013 case definition. 2013 [internet publication].Texto completo

32. Helfand RF, Heath JL, Anderson LF, et al. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J Infect Dis. 1997 Jan;175(1):195-9. Resumo

33. Ratnam S, Tipples G, Head C, et al. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol. 2000 Jan;38(1):99-104.Texto completo  Resumo

34. Centers for Disease Control and Prevention. Specimen collection, storage, and shipment. Feb 2022 [internet publication].Texto completo

35. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. Lancet. 2009 Oct 17;374(9698):1339-50. Resumo

36. Chen RT, Clark TA, Halperin SA. The yin and yang of paracetamol and paediatric immunisations. Lancet. 2009 Oct 17;374(9698):1305-6. Resumo

37. Imdad A, Mayo-Wilson E, Haykal MR, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev. 2022 Mar 16;3(3):CD008524.Texto completo  Resumo

38. Hussey GD, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990 Jul 19;323(3):160-4. Resumo

39. Yang HM, Mao M, Wan C. Vitamin A for treating measles in children. Cochrane Database Syst Rev. 2005;(4):CD001479.Texto completo  Resumo

40. Banks G, Fernandez H. Clinical use of ribavirin in measles: a summarized review. In Smith RA, Knight V, Smith JAD, eds. Clinical applications of ribavirin. New York, NY: Academic Press; 1984:203-9.

41. Ross LA, Kim KS, Mason WH, et al. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med. 1990 Mar;88(3):313-4. Resumo

42. Chen S, Wu T, Kong X, et al. Chinese medicinal herbs for measles. Cochrane Database Syst Rev. 2011;(11):CD005531.Texto completo  Resumo

43. Gadroen K, Dodd CN, Masclee GMC, et al. Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open. 2018 Nov 8;8(11):e021465.Texto completo  Resumo

44. Mina MJ, Kula T, Leng Y, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019 Nov 1;366(6465):599-606.Texto completo  Resumo